Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.
about
The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behaviorPeptide-based probes for targeted molecular imaging.Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.Peptides and peptide hormones for molecular imaging and disease diagnosisOrexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats.Radiolabeled regulatory peptides for imaging and therapyPattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in ratsCentral injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.Brain somatostatin receptor 2 mediates the dipsogenic effect of central somatostatin and cortistatin in rats: role in drinking behavior.Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretionLC/MS evaluation of metabolism and membrane transport of bombesin peptides.Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analogAbdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical studyDesign and development of molecular imaging probes.Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors.Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analoguesProspective of ⁶⁸Ga-radiopharmaceutical development.Illuminating somatostatin analog action at neuroendocrine tumor receptorsOrexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.Receptor-mediated tumor targeting based on peptide hormones.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.Radiopharmaceutical development of radiolabelled peptides.Molecular imaging probes derived from natural peptides.On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats.Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in miceActivation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureThe tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist
P2860
Q28085083-C45AB626-4EA9-4D6A-8375-47FDB0B427F2Q33526620-E1C013A1-ADCE-46CA-9D0A-5908A93EE140Q33576472-C822E739-2B6C-4E86-9CAE-FBC143BD97A2Q33846924-BCBFFA14-0275-418C-837A-434B48254DAFQ33896001-93614097-65C2-4D22-BF14-AD29706DA867Q33941027-B02948E6-2411-4A36-8CB3-449D8A0595C0Q34110022-9A0E479B-25ED-4640-8A76-B2F84BFCE81BQ34132339-6B9F2288-4CB8-4251-BA56-6FA4A47F01F3Q34295828-240C8288-BAF8-400E-AE85-EBB7D3523EC9Q34480762-2EE4C733-E038-41A2-BA60-7CCBE48DB61AQ34490275-CF0718F2-6CB1-4728-8C30-89FA2AEECFA2Q34514544-8A6F911C-9D4A-43B6-A162-E685A001B4ACQ35159637-15E94468-B34D-4D34-A45F-C237B02BCAABQ35268662-3B8A266A-37EE-42B9-BF59-30D774C7F2FBQ36125639-7D47D1C4-0788-48CE-90EA-C6BE469D8E89Q36785137-1E090B7E-2CDA-4AAA-9448-33F93957DC57Q36788491-5B9436A8-06FC-48E7-88E8-EEF67DA26BCDQ37152806-724CCC9E-0CC2-44E0-91EB-8B2FAD592DD2Q37426662-AAC4EE96-75CB-4DFE-8057-F396E08751EEQ37435222-E10DFC7F-4777-4C9F-8F63-F7D9DD790480Q37443562-140ADFD7-D1B8-4545-A995-BF9CCB30F94CQ37578127-EDE1B7AB-0CC1-4C55-8BA2-E63CA3984880Q37579225-0054A455-74E2-4C22-8017-F97D995EB361Q37641368-8F345ADB-7D7D-4111-B228-CE85E78F3AC6Q37731335-86F66334-2FBD-408A-BC11-34CA83202D62Q37975101-CC5C315C-50A7-42C5-B822-4FFBD892C8E4Q37990399-2B7A38DA-EEA7-4596-9BF2-061CD2323D42Q38748846-930F68E4-61E1-46C9-8F22-DBEEA06E97A3Q39544807-F6AFFD6C-F7A0-4F2B-BA2B-FCCB9FC64870Q40084135-54098F44-7446-4927-A40F-287443AFF1C5Q40098290-2190032E-ECA1-43CF-A1CC-B886595B72B1Q40124645-208A3CB0-0420-4232-8636-9CFFE22B9071Q41847481-8416B081-E4C2-442D-B7BE-4F61205D232FQ42519592-431D9C18-91E2-4045-ACC0-FAC80C07F2B4Q45996806-ACE343A7-E111-4FD0-9EB8-3DBEDE360C56Q52580539-3695472F-411C-4748-9FBF-26325AA9FB3EQ57144951-03654CDB-1494-455C-A158-98AF821458D5Q58803952-089FFB35-925A-4B83-B0F8-59052E20B8E2
P2860
Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Design and in vitro characteri ...... s suitable for radiotargeting.
@en
Design and in vitro characteri ...... s suitable for radiotargeting.
@nl
type
label
Design and in vitro characteri ...... s suitable for radiotargeting.
@en
Design and in vitro characteri ...... s suitable for radiotargeting.
@nl
prefLabel
Design and in vitro characteri ...... s suitable for radiotargeting.
@en
Design and in vitro characteri ...... s suitable for radiotargeting.
@nl
P2093
P2860
P356
P1476
Design and in vitro characteri ...... s suitable for radiotargeting.
@en
P2093
Beatrice Waser
Helmut R Maecke
Jean E Rivier
Judith Erchegyi
Renzo Cescato
Véronique Piccand
P2860
P304
P356
10.1021/JM701618Q
P407
P577
2008-06-11T00:00:00Z